Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ndt/gfw320 http://scihub22266oqcxt.onion/10.1093/ndt/gfw320 C5837724!5837724!27697843     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27697843.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Nephrol+Dial+Transplant 2017 ; 32 (3): 423-33 Nephropedia Template TP {{tp|p=27697843|t=2017. Peroxisome proliferator activating receptor-? and the podocyte |pdf=|usr=}}{{27697843}} gab.com Text Peroxisome proliferator activating receptor- and the podocyte JO: Nephrol Dial Transplant http://www.kidney.de/pget.php?&tw=1&pmid=27697843 #FOAvip Over the past two decades it has become clear that the glomerular podocyte is a key cell in preventing albuminuria, kidney failure and cardiovascular morbidity. Understanding the key pathways that protect the podocyte in times of glomerular stress, which can also be therapeutically manipulated, are highly attractive. In the following review we assess the evidence that the peroxisome proliferator activating receptor (PPAR) agonists are beneficial for podocyte and kidney function with a focus on PPAR-?. We explain our current understanding of the mechanisms of action of these agonists and the evidence they are beneficial in diabetic and non-diabetic kidney disease. We also outline why these drugs have not been widely used for kidney disease in the past but they may be in the future. Twit Text FOAVip Peroxisome proliferator activating receptor- and the podocyte ????Nephrol Dial Transplant http://www.kidney.de/pget.php?&tw=1&pmid=27697843 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27697843 #FOAvip English Wikipedia <ref>{{Cite pmid|27697843}}</ref> Peroxisome proliferator activating receptor-? and the podocyte #MMPMID27697843 Platt C; Coward RJ Nephrol Dial Transplant 2017[Mar]; 32 (3): 423-33 PMID27697843show ga Over the past two decades it has become clear that the glomerular podocyte is a key cell in preventing albuminuria, kidney failure and cardiovascular morbidity. Understanding the key pathways that protect the podocyte in times of glomerular stress, which can also be therapeutically manipulated, are highly attractive. In the following review we assess the evidence that the peroxisome proliferator activating receptor (PPAR) agonists are beneficial for podocyte and kidney function with a focus on PPAR-?. We explain our current understanding of the mechanisms of action of these agonists and the evidence they are beneficial in diabetic and non-diabetic kidney disease. We also outline why these drugs have not been widely used for kidney disease in the past but they may be in the future. äPeroxisome proliferator activating receptor-? and the podocyte (epmc).pdf DeepDyve Pubget Overpricing